Medical Developments International Limited Medical Developments International Limited

Medical Developments International Limited

MVP

Classement en actions #27359
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Prix de l'action
$0.28211392
Capitalisation boursière
$31.78M
Changement (1 jour)
1.27%
Changement (1 an)
-12.00%
Pays
AU
Échange Medical Developments International Limited (MVP)

Catégorie

Healthcare
EPS pour Medical Developments International Limited (MVP)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Medical Developments International Limited, l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Medical Developments International Limited de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires